Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
6 Exemplary Mexican Dishes- Fundamental Venture The board Apparatuses for Remote Groups
- The Force of Mentorship: Self-improvement through Direction
- The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles
- James Webb Space Telescope discovers a lemon-shaped exoplanet unlike anything seen before: 'What the heck is this?'
- Bomb blast in packed Nigerian mosque kills five
- Shipping: The Corridors of Trade and the Coming of Another Period
- Argentina reportedly delaying embassy move over Israeli company's oil project near Falklands
- Flu season is underway. What are common symptoms to watch for?
